Oxford BioDynamics Plc (LON:OBD – Get Free Report)’s share price fell 6.2% during mid-day trading on Tuesday . The stock traded as low as GBX 3.47 ($0.05) and last traded at GBX 3.47 ($0.05). 742,228 shares changed hands during trading, a decline of 19% from the average session volume of 913,790 shares. The stock had previously closed at GBX 3.70 ($0.05).
Analysts Set New Price Targets
Separately, Shore Capital restated a “house stock” rating on shares of Oxford BioDynamics in a report on Tuesday, June 18th.
Get Our Latest Research Report on Oxford BioDynamics
Oxford BioDynamics Trading Down 11.9 %
About Oxford BioDynamics
Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and the United Kingdom. The company provides EpiSwitch, a proprietary technology platform that enables screening, evaluation, validation, and monitoring of 3D genomic biomarkers to diagnose patients.
See Also
- Five stocks we like better than Oxford BioDynamics
- Upcoming IPO Stock Lockup Period, Explained
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- 3 Small Caps With Big Return Potential
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
- Canadian Penny Stocks: Can They Make You Rich?
- Is Aggressive Trading Your Path to Quick Profits?
Receive News & Ratings for Oxford BioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioDynamics and related companies with MarketBeat.com's FREE daily email newsletter.